• event_id: 2026-06-16-biotech-capital-cycle-phase-0a-full-rerun-captures

Fresh captures scanned: 34 tweets, ~20 Discord captures, ~40+ Reddit captures, ~11 article captures (all 2026-06-16). Grep for: TMO, TWST, XBI, IPO window, CRO, MEDP, RGEN, SDGR, ABCL, GENB, lab tools, life science.

Key captures that changed the read:

1. SPCX institutional skepticism (Reddit: r/wallstreetbets, r/stocks, r/valueinvesting; tweet @RichTerry123): Multiple high-engagement captures confirm SPCX is dominating retail attention — valuation debate, options activity, Michael Burry short commentary. One capture titled "SPCX: beware institutional money is not buying this trash on open" is an early tell that the SpaceX listing may not be the runaway "easy money flows in" scenario. If SPCX consolidates sideways rather than ripping, the digestion window may close faster than the 4–8 week worst-case estimate — mild positive for biotech timing.

2. Anthropic IPO conflict article (Semafor: "Anthropic's conflict with Washington complicates its IPO"): Incrementally negative for the AI mega-IPO supercycle parent frame. Cross-reference concern: if the supercycle parent (SpaceX digestion + Anthropic complexity) loses momentum, the biotech-capital-cycle "liquidity returns to risk assets" tailwind could be weaker than originally framed. Filed as a watch-for, not a thesis change. Most relevant to ai-power-bottleneck / Anthropic track, not biotech-capital-cycle directly.

3. IPO calendar Discord (dumb-money #long-term-investing): No biotech names in this week's IPO calendar. Consistent with the digestion window hypothesis.

4. WSB "full port healthcare" thread (155 pts, 153 comments): Early retail-breadth signal that healthcare/biotech rotation is entering the broader conversation. Not signal-grade — noted as sentiment data.

Prose update: README "What changed" section updated to incorporate these four captures. SPCX institutional skepticism added as a potentially timing-accelerating factor. Anthropic IPO complication added as a cross-reference watch-for on the parent frame. No thesis, ticker, or watchlist changes.